SEMiLLA Health BV an ezCOL company

ezCOL subsidiary SEMiLLA Health is a Dutch biotech company, that serves as the preferred valorization partner for all human and animal health technology generated by the European Space Agency (ESA) MELiSSA program. Within MELiSSA, around 100 researchers and engineers from 60 different research institutes are collaborating. Our technology pipeline addresses several health indications within primairily the cardiovascular field, of which hypercholesterolemia (raised cholesterol) is furthest developed with a first in men study completed. Our technologies target the prevention of vascular diseases by offering biological non-GMO dietary supplements, functional human food and animal feed ingredients.